Next Article in Journal
Are Putative Beta-Lactamases Posing a Potential Future Threat?
Previous Article in Journal
Machine Learning-Identified Potent Antimicrobial Peptides Against Multidrug-Resistant Bacteria and Skin Infections
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Preserving Health Beyond Infection Control: Frailty, Weight, and Cognition in OPAT Patients

1
Infectious and Tropical Diseases Unit, A.R.N.A.S. Civico-Di Cristina-Benfratelli, 90100 Palermo, Italy
2
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties “G D’Alessandro”, University of Palermo, 90100 Palermo, Italy
3
Infectious and Tropical Disease Unit, AOU Policlinico “P. Giaccone”, 90100 Palermo, Italy
4
Infectious Diseases Unit, Hospital Papardo, 98120 Messina, Italy
5
Quality and Clinical Risk Management Unit, A.R.N.A.S. Civico-Di Cristina—Benfratelli, 90100 Palermo, Italy
6
Modena HIV Metabolic Clinic, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy
*
Authors to whom correspondence should be addressed.
Antibiotics 2025, 14(11), 1173; https://doi.org/10.3390/antibiotics14111173
Submission received: 17 October 2025 / Revised: 13 November 2025 / Accepted: 18 November 2025 / Published: 20 November 2025
(This article belongs to the Special Issue Antibiotic Use and Stewardship in Settings Outside of Acute Hospitals)

Abstract

Background: Outpatient Parenteral Antimicrobial Therapy (OPAT) is a validated alternative to inpatient care for complicated infections, ensuring clinical efficacy, safety, and cost-effectiveness. However, its impact on patient-centered outcomes such as nutritional status, frailty, and cognitive well-being has rarely been studied. Methods: We conducted a multicentric retrospective observational study of patients treated with OPAT between April 2024 and July 2025 in two tertiary care hospitals. Baseline demographics, comorbidities, weight, frailty status (Rockwood Clinical Frailty Scale (CFI)), and infection-related variables were collected. Follow-up assessments evaluated body weight, frailty, and subjective cognitive status. Clinical outcomes, adverse events, and hospital readmissions were recorded. Results: Of 139 patients treated with OPAT, 119 were included in the analysis (56% male, median age 67 years). Common comorbidities were ischemic heart disease (33%), diabetes mellitus (29%), chronic pulmonary disease (22%), and solid tumors (19%). The most frequent infections were urinary tract infections (UTIs) (29%), osteomyelitis (25%), and pneumonia (17%). Multidrug-resistant (MDR) organisms were isolated in 66% of cases. Clinical recovery occurred in 82,5% of patients, while 16% required readmission in the next 30 days; no deaths were reported. Body weight (median 73 vs. 73.0 kg at baseline, p = 0.43) and frailty index (median 2.5 vs. 2.4, p = 0.16) remained stable. Cognitive status was unchanged in 85.6%, declined in 5.9%, and improved in 8.5%. Conclusions: OPAT was confirmed to be clinically robust and well tolerated, with additional potential benefits in preserving weight, frailty status, and cognitive well-being. These findings suggest that OPAT not only ensures infection control but may also protect against hospitalization-related functional decline. Prospective studies incorporating standardized geriatric and cognitive assessments are needed to confirm these preliminary findings and define OPAT’s broader role in holistic patient care.
Keywords: Outpatient Parenteral Antimicrobial Therapy (OPAT); multidrug-resistant (MDR) bacteria; frailty; body weight; subjective cognitive status Outpatient Parenteral Antimicrobial Therapy (OPAT); multidrug-resistant (MDR) bacteria; frailty; body weight; subjective cognitive status

Share and Cite

MDPI and ACS Style

Ciusa, G.; Pipitone, G.; Catania, B.; Coniglione, G.; Imburgia, C.; Marsala, M.G.L.; Scordo, P.; Albanese, A.; Cascio, A.; Guaraldi, G.; et al. Preserving Health Beyond Infection Control: Frailty, Weight, and Cognition in OPAT Patients. Antibiotics 2025, 14, 1173. https://doi.org/10.3390/antibiotics14111173

AMA Style

Ciusa G, Pipitone G, Catania B, Coniglione G, Imburgia C, Marsala MGL, Scordo P, Albanese A, Cascio A, Guaraldi G, et al. Preserving Health Beyond Infection Control: Frailty, Weight, and Cognition in OPAT Patients. Antibiotics. 2025; 14(11):1173. https://doi.org/10.3390/antibiotics14111173

Chicago/Turabian Style

Ciusa, Giacomo, Giuseppe Pipitone, Bianca Catania, Giulia Coniglione, Claudia Imburgia, Maria Grazia Laura Marsala, Preziosa Scordo, Antonio Albanese, Antonio Cascio, Giovanni Guaraldi, and et al. 2025. "Preserving Health Beyond Infection Control: Frailty, Weight, and Cognition in OPAT Patients" Antibiotics 14, no. 11: 1173. https://doi.org/10.3390/antibiotics14111173

APA Style

Ciusa, G., Pipitone, G., Catania, B., Coniglione, G., Imburgia, C., Marsala, M. G. L., Scordo, P., Albanese, A., Cascio, A., Guaraldi, G., & Iaria, C. (2025). Preserving Health Beyond Infection Control: Frailty, Weight, and Cognition in OPAT Patients. Antibiotics, 14(11), 1173. https://doi.org/10.3390/antibiotics14111173

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop